Interferon-γ Targets Cancer Cells and Osteoclasts to Prevent Tumor-associated Bone Loss and Bone Metastases
Zhiqiang Xu(Washington University in St. Louis), Katherine N. Weilbaecher(Washington University in St. Louis)
Cited by 45
Related Papers
Breast cancer–derived GM-CSF regulates arginase 1 in myeloid cells to promote an immunosuppressive microenvironment
|Journal of Clinical Investigation|2021|111
The ADP receptor P2RY12 regulates osteoclast function and pathologic bone remodeling
|Journal of Clinical Investigation|2012|102
Hedgehog Signaling Inhibition Blocks Growth of Resistant Tumors through Effects on Tumor Microenvironment
|Cancer Research|2011|78
Targeted Therapy to β3 Integrin Reduces Chemoresistance in Breast Cancer Bone Metastases
|Molecular Cancer Therapeutics|2021|22
HTLV-1 viral oncogene HBZ drives bone destruction in adult T cell leukemia
|JCI Insight|2019|21